Marinus Pharma (MRNS) Announces Ganaxolone Orphan Epilepsy Program Updates Including Planned Clinical Program in TSC

Go back to Marinus Pharma (MRNS) Announces Ganaxolone Orphan Epilepsy Program Updates Including Planned Clinical Program in TSC
(NASDAQ: MRNS) Delayed: 0.55 --0 (-0%)
Previous Close $0.55    52 Week High $8.12 
Open $0.55    52 Week Low $1.02 
Day High $0.55    P/E N/A 
Day Low $0.55    EPS $0.00 
Volume 1,518